Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin

Minna Lehtisalo, Jenni E. Keskitalo, Aleksi Tornio, Outi Lapatto-Reiniluoto, Feng Deng, Taina Jaatinen, Jenni Viinamäki, Mikko Neuvonen, Janne T. Backman, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical and translational science
Number of pages8
ISSN1752-8054
DOIs
Publication statusE-pub ahead of print - 26 May 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • DRUG-DRUG INTERACTION
  • HEPATIC-UPTAKE
  • ABCG2 BCRP
  • PHARMACOKINETICS
  • TRANSPORTER
  • GOUT
  • ELTROMBOPAG
  • OATP1B1
  • RISK
  • ATORVASTATIN

Cite this